| Description |
PGE1-[d9] is the labelled analogue of Prostaglandin-E1. Prostaglandin-E1 is used as a drug in the treatment of erectile dysfunction and has vasodilatory properties. It can be used as a vasodilator agent increasing peripheral blood flow. |
| Synonyms |
Prostaglandin E1-d9; PGE1-d9; (11α,13E,15S)-11,15-Dihydroxy-9-oxo(17,17,18,18,19,19,20,20,20-d9)prost-13-en-1-oic acid; Prost-13-en-1-oic-17,17,18,18,19,19,20,20,20-d9 acid, 11,15-dihydroxy-9-oxo-, (11α,13E,15S)-; (11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic Acid-d9; Alprostadil-d9; Alprox TD-d9; Caveject-d9; Liprostin-d9; Palux-d9; Prostandin-d9; Minprog-d9; NSC 165559-d9; Topiglan-d9; Vasaprostan-d9; l-PGE1-d9; l-Prostaglandin E1-d9 |
| IUPAC Name |
7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl-5,5,6,6,7,7,8,8,8-d9)-5-oxocyclopentyl)heptanoic acid |
| Related CAS |
745-65-3 (unlabelled)
|
| Canonical SMILES |
[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C[C@H](O)/C=C/[C@@H]1[C@@H](CCCCCCC(O)=O)C(=O)C[C@H]1O |
| InChI |
InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,19+/m0/s1/i1D3,2D2,3D2,6D2 |
| InChI Key |
GMVPRGQOIOIIMI-XRKMKCTBSA-N |
| Purity |
>99% |
| Solubility |
Soluble in DMSO (Slightly), Methanol (Slightly), THF (Slightly) |
| Appearance |
Off-white Solid |
| Shelf Life |
1 Year |
| Storage |
Store at -20°C |
![PGE1-[d9]](/isotope.v1/images/structure-default.jpg)
